Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000672102 | SCV000797167 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2018-01-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001231865 | SCV001404401 | pathogenic | not provided | 2019-08-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp2523*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant has been observed in an individual affected with retinitis pigmentosa (PMID: 26496393). ClinVar contains an entry for this variant (Variation ID: 556144). |
Genome- |
RCV003453343 | SCV004183233 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453342 | SCV004183234 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003453343 | SCV004206386 | pathogenic | Retinitis pigmentosa 39 | 2022-10-01 | criteria provided, single submitter | clinical testing |